Xenetic Biosciences, Inc. Forecast, price target & analysts
Xenetic Biosciences, Inc. Target price 2024 - Analyst rating & recommendation
Xenetic Biosciences, Inc. Classifications & Recommendation:
Xenetic Biosciences, Inc. Price Target
| Target Price | $40.00 |
| Price | $3.69 |
| Potential |
984.01%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Xenetic Biosciences, Inc. price target 2025.
The average Xenetic Biosciences, Inc. target price is $40.00.
This is
984.01%
register free of charge
|
|
| A rating was issued by 1 analysts: 0 Analysts recommend Xenetic Biosciences, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Xenetic Biosciences, Inc. stock has an average upside potential 2025 of
984.01%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 2.54 | 2.20 |
| 48.54% | 13.39% | |
| EBITDA Margin | -177.95% | -281.82% |
| 54.51% | 58.37% | |
| Net Margin | -164.31% | -455.00% |
| 60.42% | 176.92% |
1 Analyst has issued a sales forecast Xenetic Biosciences, Inc. 2024 . The average Xenetic Biosciences, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Xenetic Biosciences, Inc. 2024 . The average Xenetic Biosciences, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
The average Xenetic Biosciences, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2023 | $-4.2m | 41.21% |
|---|---|---|
| 2024 |
$-10.0m
139.85%
Unlock
|
|
Net Margin
| 2023 | -164.31% | 60.42% |
|---|---|---|
| 2024 |
-455.00%
176.92%
Unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.71 | -6.50 |
| 41.21% | 139.85% | |
| P/E | negative | |
| EV/Sales | negative |
The average Xenetic Biosciences, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2023 | $-2.71 | 41.21% |
|---|---|---|
| 2024 |
$-6.50
139.85%
Unlock
|
|
P/E ratio
| Current | -1.39 | 39.00% |
|---|---|---|
| 2024 |
-0.57
58.99%
Unlock
|
|
Based on analysts' sales estimates for 2024, the Xenetic Biosciences, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Xenetic Biosciences, Inc....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
